City
Epaper

Lucknow labs included in Covid surveillance grid

By IANS | Published: August 25, 2021 9:33 AM

Lucknow, Aug 25 The virology labs at Central Drug Research Institute (CDRI) and National Botanical Research Institute (NBRI) ...

Open in App

Lucknow, Aug 25 The virology labs at Central Drug Research Institute (CDRI) and National Botanical Research Institute (NBRI) in Lucknow have been included in Indian Sars Cov-2 Genomic Surveillance Consortium (INSACOG) a conglomerate of 28 laboratories across the country.

The consortium was set up by the Union health ministry, department of biotechnology with Council for Scientific Research and Indian Council of Medical Research to monitor genomic variations in Sars Cov-2.

It also works to correlate whole genomics sequencing (WGS) data with clinical/epidemiological data for advance preparedness for public health interventions and better understanding of disease transmission, clinical severity, re-infections/immune escape, vaccine efficacy and available diagnostics tests.

An official order issued by the Union Ministry of Health and Family Welfare has listed the two labs as a satellite centre that will work in coordination with Delhi-based Institute of Genomics and Integrative Biology.

The order stated, "Over the past few months, many variants have been detected through whole genome sequencing activity undertaken by INSACOG. The information obtained has been regularly shared with states and union territories to strengthen public health response to the pandemic. For the exercise to become meaningful, it is necessary that timely clinical data and adequate number of RT-PCR positive samples for genome sequencing and surveillance work is done by states too."

Experts say genome sequencing is crucial to countering the pandemic amid reports of an anticipated third wave and extent of damage will depend on the new strain.

Indications are that if no new variant surfaces, the third wave may not be lethal. But if the virus mutates again, the third wave may cause more harm.

Officials at the National Diseases Surveillance Programme unit of Uttar Pradesh said, samples will now be sent for genome sequencing to these labs as well.

Earlier, a section of Covid-19 samples was being sent to the Sanjay Gandhi Post Graduate Institute of Medical Sciences and King George's Medical University.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Central drug research instituteNational botanical research institute
Open in App

Related Stories

NationalJharkhand's Jurassic Park a treasure trove of prehistoric fossils

HealthCDRI research on new drug for Covid

NationalDengue Fever: Scientists found drug for dengue, soon be tested at 20 centers

HealthClinical trial of Umifenovir proves successful in treating Covid

InternationalNBRI to help turn Lucknow into natural oxygen hub

Health Realted Stories

HealthSouth Korea reports first 'highly pathogenic' bird flu case in more than three months

HealthDelhi HC closes PIL on medicine shortage in Rajan Babu Institute after govt's assurance

HealthH5N1 Bird Flu Human Cases in US & Australia Cause Concern: Know the Reason

HealthEpidurals can cut risk of severe childbirth complications by 35 pc: Study

Health1st India made surgical robotic system SSI Mantra performs 100 cardiac surgeries